Académique Documents
Professionnel Documents
Culture Documents
JD Middleton
Ball State University
Intern Case
October 9th, 2018 Study
Presentation
Outline
Associated with:
longer LOS1
Increased healthcare-related costs1
Increased rates of further health-related complications1
Slower wound healing3
Higher risk of falls3
Lab levels historically used for diagnosis1
Albumin
Pre-albumin
Patient history and nutrition-focused physical exam (NFPE) used today1
NFPE assesses nutritional status by focusing on edema, muscle wasting, and subcutaneous fat wasting
Protein Calorie Malnutrition (PCM) cont.
Total
Parenteral
Nutrition (TPN)
Feeding intravenously and bypassing all of
the GI tract
https://www.google.com/url?sa=i&rct=j&q=&esrc=s&source=images&cd=&ved=2ahUKEwjs_fHGk_jdAhUCSK
0KHWWTAUAQjRx6BAgBEAU&url=https%3A%2F%2Fwww.infusionsolutionsinc.com%2F2015%2Fcompany_news
%2Ffocus-on-therapy-what-is-tpn&psig=AOvVaw0z--MpO0VfGwZNAeG-zjb9&ust=1539133047458611
Percutaneous
Endoscopic
Gastrostomy
(PEG)
Feeding tube placed through the
abdominal wall and into the stomach to https://i1.wp.com/ajnoffthecharts.com/wp-content/uploads/2015/06/figure2-
bypass the mouth and esophagus pegtubedisplacement.png?zoom=2&resize=242%2C196&ssl=1
Gastro-
Jejunal (G-J)
Tube
Extension of the PEG tube into the small
intestine to bypass the stomach
https://ars.els-cdn.com/content/image/1-s2.0-S0025619611630577-gr1.gif
Introduction to the Subject
Patient Intro
78 years old
Caucasian
Female
Frequently admitted for abdominal pain among other complaints/complications
Resides at skilled nursing facility
Patient History
Admit 6/29/18-7/20/18
7/17/18 7/20/18
Poor PO continues D/C to SNF
Diet changed to regular
Continues to receive Magic
Cup
Admit 8/12/18-9/5/18
8/30/18 9/2/18-9/3/18
9/5/18
Diet: NPO Residuals over 100 mL and TF
TF at goal rate of 45 mL/hr w/
pushed back to 35 mL/hr
PEG placed better tolerance
Advanced back up to goal
D/C to SNF
rate of 45 mL/hr
8/31/18
TF starts- Jevity1.2 @ 45 mL/hr
Will provide 100% of
nutritional needs
Admit 9/21/18-Present
Admitted for anemia, complicated UTI, metabolic acidosis, and abdominal pain
Pt came from SNF and was receiving Vital 1.2 @ 35 mL/hr and abdominal pain started
Anthropometrics at admit:
Height: 152.4 cm
Weight: 51 kg
BMI: 22 (normal)
Needs: 1275-1530 kcal, 64-77 PRO, 1500 mL
PES Statement
Inadequate oral/beverage intake (NI-2.1) RT decreased appetite AEB poor PO intake and need
for TF to meet nutritional needs
Nutritional Diagnosis
Severe protein calorie malnutrition related to chronic illness as evidence by severe muscle
wasting (clavicles, shoulders), 3+ generalized edema, and 4+ BUE edema (forearms)
Admit 9/21/18-Present
Pertinent Dates
9/28/18
9/24/18 9/27/18
Vital 1.2 @ goal rate of 30
Diet: Regular w/ Vital 1.2 Diet: Regular w/ Vital 1.2 was not tolerated and
@ 40 mL/hr (1152 kcal, 72 @ 20 mL/hr (576 kcal, 36 d/c
PRO) PRO)
TPN @ 60 mL/hr started
Abdominal pain TF running at goal rate (1022 kcal, 72 PRO)
continues and TF d/c
45% meal PO intake Family member states PO
TF advanced to new goal intake causes worse
rate of 30 mL/hr abdominal pain
9/25/18
10/2/18
Vital 1.2 w/ goal rate of 20
mL/hr started Thoracentesis removed
500 mL of pleural fluid
Admit 9/21/18-Present
Pertinent Dates
10/4/18
10/3/18 10/5/18
Diet: Regular w/ TPN @ 60
Diet: Regular w/ TPN @ 60 TwoCal HN running at 30
mL/hr and TwoCal HN
mL/hr (1022 kcal, 72 PRO) mL/hr
advancement running at
EGD found no same time 25% meal PO intake
abnormalities and MD Pharmacist calls RD to Tolerating TF
wants TF to start again discuss when to stop TPN advancement and PO
RD puts in order for intakes better tolerated
RD suggests running TPN
TwoCal HN @ 30 mL/hr after pleural fluid
for rest of the day and d/c
(1440kcal, 60 PRO) w/ removed
it tomorrow (10/5)
slow advancement while
weaning off TPN
Admit 9/21/18-Present
Pertinent Dates
10/8/18
Diet: Regular w/ TwoCal
HN @ 30 mL/hr (1440 kcal,
60 PRO)
12% PO meal intake
TF running at goal rate
Tolerating well w/ no
abdominal pain
Medical Tests/Procedures
Hgb 8.5 8.3 7.8 8.3 8.6 8.4 8.2 8.3 9.1 7.0 6.7 9.2 15.5 9.6
(11.5-
15.2)
Hct 27.2 26.1 24.7 26.3 27.3 26.5 25.9 26.7 29.6 22.0 20.9 27.8 46.9 29.5
(34.4-
45.6)
Na 138 138 141 145 145 141 143 143 141 136 136 135 136 134 137 137 137
(136-145)
K 5.5 5.7 3.6 3.6 3.4 3.0 3.0 3.6 4.5 5.1 5.3 4.3 3.9 3.6 3.3 3.7 4.1
(3.5-5.5)
Cl 116 115 115 118 119 118 117 117 116 112 110 111 111 111 113 112 112
(98-110)
BUN 52 49 42 36 36 35 31 29 32 32 32 33 33 32 27 24 23
(10-20)
Cr 1.15 1.09 0.97 0.86 0.86 0.90 0.80 0.78 0.71 0.66 0.64 0.61 0.57 0.60 0.62 0.61 0.61
(0.70-1.2)
Glu 96 97 122 90 100 129 95 156 151 128 137 133 125 93 112 117 126
c
(65-99)
Ca 8.5 8.3 8.2 7.9 8.0 8.1 8.1 7.8 7.7 7.6 8.1 7.7 7.7 7.9 8.1 8.2 8.3
(8.4-10.5)
Medications
Name Type Use
Lomotil Gastrointestinal agent Antidiarrheal
Buspar CNS agent Anxiolytic, sedative, hypnotic
Dextrose 5% + 10 mEq KCl Nutritional product IV nutritional product
Magnesium Sulfate Nutritional product Minerals and electrolytes
Sodium Chloride Nutritional product Minerals and electrolytes
Clinimix 5/15 Nutritional product (TPN) IV nutritional product
Lovenox Coagulation modifiers Anticoagulant
Fentanyl CNS agent Analgesic
Trandate Cardiovascular agent Beta-adrenergic blocking agent
Lactaded Ringers Nutritional product IV nutritional product
Zofran CNS agent Antiemetic/antivergo agent
Sodium Phosphate Nutritional product Minerals and electrolytes
Lasix Cardiovascular agent Diuretic
Potassium Phosphate Nutritional product Minerals and electrolytes
Florastor Cap Alternative medicine Probiotic
Desyrel Psychotherapeutic agent Antidepressent
Medications Cont.
Name Type Use
Barium Sulfate Radiologic agent Radiocontrast agent
Sodium Bicarb Gastrointestinal agent Antacid
Ceftin Anti-Infective Cephalosporin
Vitamin B12 Nutritional product Vitamin
Benadryl Respiratory agent Antihistamine
Tylenol CNS agent Analgesic
Norvasc Cardiovascular agent Calcium channel blocking agent
Norco CNS agent Analgesic
Coreg Cardiovascular agent Beta-adrenergic blocking agent
Clonidine Patch Cardiovascular agent Antiadrenergic agent
Pepcid Gastrointestinal agent H2 antagonist
Folic Acid Nutritional product Vitamin
Apresoline Cardiovascular agent Vasodilator
Protonix Gastrointestinal agent Proton pump inhibitor
Xifaxan Anti-infective Miscellaneous antibiotic
Proposed Outcomes to
Monitor and Evaluate
Monitoring and Evaluating
Goals
Continue to meet nutritional goals
Prevent further weight loss and wasting
Progress PO intake
Monitoring
No abdominal pain
Residuals <250 mL
Weight changes
Abnormal labs
Proposed Outcomes
https://i2.wp.com/thestentedpapa.com/wp-content/uploads/2018/02/Screen-Shot-2018-02-09-at-12.30.05.png?w=883
https://i2.wp.com/thestentedpapa.com/wp-content/uploads/2018/02/Screen-Shot-2018-02-09-at-12.30.05.png?w=883